CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor-Reference-Cited by-同舟云学术

CD36+/CD61+ Microparticles Correlate with the Risk of Percutaneous Cardiac Interventions in Coronary Artery Disease Patients and the Effects of Ticagrelor

Published:2021-04-24 Issue: Volume: Page:
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Zhou Xue,Liu Xing,Liu Hongmei,Dou Shuang,Chen Kangyin,Zhang Xiaowei,Wang Weiding,Wang Xuewen,Che Jingjin^ORCID

Funder

the National Natural Science Foundation of China Youth Program

Tianjin Science and Technology Committee

the Tianjin Health and Family Planning Commission Foundation

the Tianjin Graduate Scientific Research Innovation Program

the Key Laboratory Fund of the Second Hospital of Tianjin Medical University

the Science & Technology Development Fund of Tianjin Education Commission for Higher Education

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10557-021-07184-0.pdf

Reference40 articles.

1. Sluijter J, Davidson S, Boulanger C, et al. Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2018;114:19–34.

2. Shantsila E, Kamphuisen P, Lip G. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemostasis. 2010;8:2358–68.

3. Voukalis C, Shantsila E, Lip G. Microparticles and cardiovascular diseases. Ann Med. 2019;51:193–223.

4. Sinauridze E, Kireev D, Popenko N, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97:425–34.

5. Tan K, Tayebjee M, Lynd C, Blann A, Lip G. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med. 2005;37:61–6.